{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:10:36Z","timestamp":1789607436066,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,23]],"date-time":"2027-06-23T00:00:00Z","timestamp":1813708800000},"content-version":"am","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jacc.2026.01.059","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:36:34Z","timestamp":1773239794000},"page":"3452-3463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genotype-Guided Risk Stratification of Mitral Valve Surgery in Marfan Syndrome"],"prefix":"10.1016","volume":"87","author":[{"given":"Yuki","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiharu","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2754-5628","authenticated-orcid":false,"given":"Yoshitsugu","family":"Nogimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Shiraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-689X","authenticated-orcid":false,"given":"Ryo","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2026.01.059_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2026.01.059_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.jacc.2026.01.059_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41436-021-01132-x","article-title":"Clinical relevance of genotype-phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic variants","volume":"23","author":"Arnaud","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2026.01.059_bib4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/jamacardio.2021.2312","article-title":"Association of mitral annular disjunction with cardiovascular outcomes among patients with Marfan syndrome","volume":"6","author":"Demolder","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2026.01.059_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2022.100149","article-title":"Genotype-mitral valve phenotype correlations in Marfan syndrome with FBN1 pathogenic variants","volume":"1","author":"Delhomme","year":"2022","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacc.2026.01.059_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0003-4975(03)01584-4","article-title":"Fibrillin and other matrix proteins in mitral valve prolapse syndrome","volume":"77","author":"Nasuti","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2026.01.059_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ijcard.2012.10.044","article-title":"FBN1 gene mutation characteristics and clinical features for the prediction of mitral valve disease progression","volume":"168","author":"K\u00fchne","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2026.01.059_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.040947","article-title":"Clinical and phenotypic correlates of mitral valve prolapse in Marfan syndrome: the Cornell aortic aneurysm registry","volume":"14","author":"Narula","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2026.01.059_bib9","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1161\/CIR.0000000000001265","article-title":"Cardiovascular management of aortopathy in children: a scientific statement from the American Heart Association","volume":"150","author":"Morris","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.01.059_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/520125","article-title":"Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study","volume":"81","author":"Faivre","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2026.01.059_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13023-017-0754-6","article-title":"The importance of genotype-phenotype correlation in the clinical management of Marfan syndrome","volume":"13","author":"Becerra-Mu\u00f1oz","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jacc.2026.01.059_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/341581","article-title":"Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes","volume":"71","author":"Schrijver","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2026.01.059_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U","article-title":"Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene","volume":"62","author":"Putnam","year":"1996","journal-title":"Am J Med Gen"},{"key":"10.1016\/j.jacc.2026.01.059_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ejhg.2008.207","article-title":"Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation","volume":"17","author":"Faivre","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacc.2026.01.059_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1203\/PDR.0b013e3182097219","article-title":"Prognosis factors in probands with an FBN1 mutation diagnosed before the age of 1 year","volume":"69","author":"Stheneur","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jacc.2026.01.059_bib16","article-title":"Impact of pathogenic FBN1 variant types on the progression of aortic disease in patients with Marfan syndrome","volume":"11","author":"Takeda","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacc.2026.01.059_bib17","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(23)02755-1","article-title":"Valvular heart disease: from mechanisms to management","volume":"403","author":"Praz","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.01.059_bib18","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(23)02754-X","article-title":"The future of valvular heart disease assessment and therapy","volume":"403","author":"Sengupta","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.01.059_bib19","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/hmg\/ddv037","article-title":"The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele","volume":"24","author":"Aubart","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacc.2026.01.059_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-2-11","article-title":"Multi-exon deletions of the FBN1 gene in Marfan syndrome","volume":"2","author":"Liu","year":"2001","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jacc.2026.01.059_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13073-024-01423-3","article-title":"Interpretation and classification of FBN1 variants associated with Marfan syndrome: consensus recommendations from the Clinical Genome Resource\u2019s FBN1 variant curation expert panel","volume":"16","author":"Drackley","year":"2024","journal-title":"Genome Med"},{"key":"10.1016\/j.jacc.2026.01.059_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2026.01.059_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jmedgenet-2021-108186","article-title":"Impact of pathogenic FBN1 variant types on the development of severe scoliosis in patients with Marfan syndrome","volume":"60","author":"Taniguchi","year":"2023","journal-title":"J Med Genet"},{"key":"10.1016\/j.jacc.2026.01.059_bib24","article-title":"Genotype-phenotype correlations of Marfan syndrome and related fibrillinopathies: phenomenon and molecular relevance","volume":"13","author":"Chen","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.jacc.2026.01.059_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.200608167","article-title":"Fibrillin-1 regulates the bioavailability of TGFbeta1","volume":"176","author":"Chaudhry","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jacc.2026.01.059_bib26","first-page":"D506","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Dogan","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacc.2026.01.059_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2026.01.059_bib28","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1253\/circj.CJ-20-0135","article-title":"JCS\/JSCS\/JATS\/JSVS 2020 guidelines on the management of valvular heart disease","volume":"84","author":"Izumi","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2026.01.059_bib29","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1253\/circj.CJ-24-0291","article-title":"Mitral valve repair for mitral regurgitation in patients with Marfan syndrome","volume":"88","author":"Tanaka","year":"2024","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2026.01.059_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1214\/aos\/1176344198","article-title":"Nonparametric estimation of partial transition probabilities in multiple decrement models","volume":"6","author":"Aalen","year":"1978","journal-title":"Ann Stat"},{"key":"10.1016\/j.jacc.2026.01.059_bib31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.jacc.2026.01.059_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.32614\/RJ-2014-028","article-title":"Bshazard: A flexible tool for nonparametric smoothing of the hazard function","volume":"6","author":"Rebora","year":"2014","journal-title":"R J"},{"key":"10.1016\/j.jacc.2026.01.059_bib33","doi-asserted-by":"crossref","first-page":"18232","DOI":"10.1074\/jbc.RA119.011109","article-title":"A disease-associated mutation in fibrillin-1 differentially regulates integrin-mediated cell adhesion","volume":"294","author":"Del Cid","year":"2019","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.jacc.2026.01.059_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183558","article-title":"Integrin-mediated mTOR signaling drives TGF-\u03b2 overactivity and myxomatous mitral valve degeneration in hypomorphic fibrillin-1 mice","volume":"135","author":"Gao","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2026.01.059_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.carpath.2017.10.003","article-title":"Betaglycan (TGFBR3) up-regulation correlates with increased TGF-\u03b2 signaling in Marfan patient fibroblasts in vitro","volume":"32","author":"Groeneveld","year":"2018","journal-title":"Cardiovasc Pathol"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972600238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972600238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:17:23Z","timestamp":1782227843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972600238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S073510972600238X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.01.059","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotype-Guided Risk Stratification of Mitral Valve Surgery in Marfan Syndrome","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.01.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}